Compounds > oleanolic acid
Page last updated: 2024-08-21

oleanolic acid and B-Cell Chronic Lymphocytic Leukemia

oleanolic acid has been researched along with B-Cell Chronic Lymphocytic Leukemia in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andreeff, M; Bennett, F; Charboneau, L; Kim, Y; Kipps, TJ; Kitada, S; Liotta, LD; Pedersen, IM; Rassenti, L; Reed, JC; Schimmer, A; Sporn, MB; Zapata, JM1
Cohen, GM; Dyer, MJ; Inoue, S; Snowden, RT1
Andreeff, M; Hyer, ML; Konopleva, M; Krajewska, M; Kress, CL; Lefebvre, S; Martínez-García, V; McQueen, T; Reed, JC; Zapata, JM1
Chu, P; Deforce, D; Kim, Y; Kipps, TJ; Kitada, S; Pedersen, IM; Reed, JC1

Other Studies

4 other study(ies) available for oleanolic acid and B-Cell Chronic Lymphocytic Leukemia

ArticleYear
The triterpenoid CDDO induces apoptosis in refractory CLL B cells.
    Blood, 2002, Oct-15, Volume: 100, Issue:8

    Topics: Antineoplastic Agents; Apoptosis; B-Lymphocytes; Caspases; Drug Resistance, Neoplasm; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Nitric Oxide; Oleanolic Acid; Vidarabine

2002
CDDO induces apoptosis via the intrinsic pathway in lymphoid cells.
    Leukemia, 2004, Volume: 18, Issue:5

    Topics: Apoptosis; Caspase 9; Caspases; Humans; Jurkat Cells; Leukemia, Lymphocytic, Chronic, B-Cell; Leupeptins; Oleanolic Acid

2004
Triterpenoids display single agent anti-tumor activity in a transgenic mouse model of chronic lymphocytic leukemia and small B cell lymphoma.
    PloS one, 2007, Jun-27, Volume: 2, Issue:6

    Topics: Animals; B-Lymphocytes; Cell Survival; Disease Models, Animal; Female; Flow Cytometry; Gene Deletion; Humans; Immunoenzyme Techniques; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Male; Mice; Mice, Inbred BALB C; Mice, Transgenic; Oleanolic Acid; Proto-Oncogene Proteins c-bcl-2; T-Lymphocytes; TNF Receptor-Associated Factor 2

2007
Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia.
    Proceedings of the National Academy of Sciences of the United States of America, 2002, Mar-19, Volume: 99, Issue:6

    Topics: Animals; Apoptosis; Carrier Proteins; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase 8; Caspase 9; Caspases; CD4-Positive T-Lymphocytes; CD40 Antigens; CD40 Ligand; CHO Cells; Cricetinae; Down-Regulation; Fas Ligand Protein; fas Receptor; Gene Expression Regulation, Neoplastic; Genetic Therapy; Humans; Intracellular Signaling Peptides and Proteins; Leukemia, Lymphocytic, Chronic, B-Cell; Membrane Glycoproteins; Oleanolic Acid; Precipitin Tests; Signal Transduction; Time Factors; Tumor Cells, Cultured

2002